Jordan vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Jordan
100.0%
in 2024
Sur
82.0%
in 2024
Jordan rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Jordan
- Sur
How they compare
Jordan currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Jordan's figure about 1.2 times Sur's.
Across all 5 years both countries report, Jordan has been ahead every year.
Jordan ranks 1st and Sur ranks 2nd of 144 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 65.0% | 35.0% | Jordan |
| 2020s | 100.0% | 67.5% | 32.5% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Jordan or Sur?
- Jordan, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Jordan and Sur?
- 18.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Sur?
- 5 years are reported by both, from 2011 to 2024.
- How do Jordan and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Jordan ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.